BIOCRYST PHARMACEUTICALS, INC. Shares Issued, Price Per Share
BIOCRYST PHARMACEUTICALS, INC. (BCRX) had Shares Issued, Price Per Share of $4.50 per share as of 2020-06-01, per its 10-K filed 2023-02-27.
Discontinued › Notes › Equity › Stockholders' Equity Note
us-gaap:SharesIssuedPricePerShare · last filed 2023-02-27
- 2020-06-01: Shares Issued, Price Per Share $4.50.
- 2019-11-21: Shares Issued, Price Per Share $1.69.
- 2019-11-18: Shares Issued, Price Per Share $1.45.
- 2018-08-06: Shares Issued, Price Per Share $5.50.
| Period end | Shares Issued, Price Per Share |
|---|---|
| 2020-06-01 | $4.50 10-K · filed 2023-02-27 |
| 2019-11-21 | $1.69 10-K · filed 2022-02-28 |
| 2019-11-18 | $1.45 10-K · filed 2022-02-28 |
| 2018-08-06 | $5.50 10-K · filed 2021-03-01 |
| 2017-09-30 | $5.15 10-K · filed 2019-03-14 |
| 2017-03-31 | $8.50 10-K · filed 2019-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |